Retatrutide, from Soma Corp., is gaining considerable attention as a potential treatment for weight management . This innovative compound merges the properties of a GLP-1 receptor stimulant and a GIP receptor stimulant, aiming to simply promote reduced body fat but also target associated metabolic conditions . Early human trials have demonstrated i